The global DNA nanotechnology market size is expected to reach USD 24.2 billion by 2033, registering a CAGR of 21.1% from 2026 to 2033, according to a new report by Grand View Research, Inc. This growth is driven by rising demand for targeted drug delivery, advanced diagnostics, AI integration in nanostructure design, and increased R&D investments in healthcare and biotechnology sectors.
Furthermore, DNA nanostructures enable precise delivery of therapeutics, reducing side effects and improving treatment outcomes. This precision is especially valuable in oncology, where targeted delivery can minimize damage to healthy cells. In addition, these nanostructures offer programmability and biocompatibility, making them ideal carriers for a wide range of drugs and genetic materials. DNA nanotechnology is crucial in developing patient-specific therapies as personalized medicine gains traction. These innovations are accelerating the adoption of DNA nanostructures in modern drug delivery systems and broader biomedical applications, combined with advancements in AI and nanofabrication.
The COVID-19 pandemic further accelerated the demand for DNA nanotechnology owing to its potential in rapid diagnostics, vaccine development, and targeted drug delivery. DNA-based nanostructures were explored for their ability to detect viral RNA with high sensitivity and support the design of novel therapeutic platforms. The urgent need for advanced biomedical tools during the pandemic highlighted the versatility and scalability of DNA nanotech, driving increased investment and research in the field.
In addition, AI is enhancing the design and efficiency of DNA nanodevices by accelerating structural predictions, optimizing assembly pathways, and improving functional accuracy. Machine learning algorithms enable rapid simulation and analysis, reducing development time and costs. This integration of AI supports the creation of more stable, complex, and application-specific nanostructures, further expanding the potential of DNA nanotechnology in medicine, diagnostics, and nanomaterials.
However, designing and synthesizing DNA nanostructures remains expensive and resource-intensive, which is anticipated to hamper market growth. This is attributed to the need for specialized equipment, skilled expertise, and time-consuming validation processes. These factors increase production costs and limit scalability, posing challenges for widespread adoption. Addressing these limitations will be critical for sustaining long-term market expansion.
Request a free sample copy or view report summary: DNA Nanotechnology Market Report
Based on technology type, the structural DNA nanotechnology segment accounted for the largest revenue share, over 61.5% in 2025. These rigid and customizable DNA-based frameworks are essential for building nanoscale devices, drug delivery carriers, and biosensors with consistent performance and spatial accuracy.
Based on application, the drug delivery systems segment dominated the market in 2025, accounting for 42.2%. DNA nanostructures offer unparalleled programmability, biocompatibility, and the ability to encapsulate and release drugs in response to specific biological signals, minimizing off-target effects and improving treatment outcomes.
Based on end use, the academic & research institutions segment dominated the market, accounting for 52.3% of the market in 2025. Driven by extensive research in DNA nanostructures, nanomedicine, and molecular engineering, supported by government and institutional funding.
North America dominated the DNA nanotechnology industry, accounting for the largest revenue share of 59.1% in 2025 and projected to grow at the highest CAGR over the forecast period, due to its strong research and development infrastructure, substantial investments in biotech and healthcare, and leading-edge advancements in nanotechnology applications.
Grand View Research has segmented the global DNA nanotechnology market based on technology type, application, end use, and region:
DNA Nanotechnology Technology Outlook (Revenue, USD Million, 2021 - 2033)
Dynamic DNA Nanotechnology
Extended Lattices
Discrete Structures
Template Assembly
Others
Structural DNA Nanotechnology
Nanomechanical Devices
Strand Displacement Cascades
Others
DNA Nanotechnology Application Outlook (Revenue, USD Million, 2021 - 2033)
Drug Delivery Systems
Diagnostics and Biosensing Development
Material Science and Nanoassembly
Others
DNA Nanotechnology End Use Outlook (Revenue, USD Million, 2021 - 2033)
Academic & Research Institutions
Biotechnology and Pharmaceuticals
Others
DNA Nanotechnology Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
UAE
Saudi Arabia
Kuwait
List of Key Players in theDNA Nanotechnology Market
GATTAquant GmbH
NanoBio Designs, Inc.
Tilibit Nanosystems
Helixworks
SomaLogic Operating Co., Inc.
EnaChip Inc.
Ginkgo Bioworks
Nanolab Technologies (acquired by Eurofins Scientific)
Nanogami
DNA Nanobots, Inc.
"The quality of research they have done for us has been excellent..."